Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:SLDB), CHARLESTOWN, Mass., July 01, 2025 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB) (the “Company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 105,330 restricted stock units (“RSUs”) to seven newly hired employees. The RSUs vest in four equal installments on each one-year anniversary of […]

Robinhood Markets, Inc. to Announce Second Quarter 2025 Results on July 30, 2025

(NASDAQ:HOOD), MENLO PARK, Calif., July 01, 2025 (GLOBE NEWSWIRE) — Today, Robinhood Markets, Inc. (“Robinhood”) (NASDAQ: HOOD) announced that it will release its second quarter 2025 financial results on Wednesday, July 30, 2025, after market close. Robinhood will host a video call to discuss its results at 2:00 PM PT / 5:00 PM ET on

Covenant Logistics Group, Inc. Announces Timing of Second Quarter Earnings Release an Conference Call

(NYSE:CVLG), CHATTANOOGA, Tenn., July 01, 2025 (GLOBE NEWSWIRE) — Covenant Logistics Group, Inc. (NYSE: CVLG) announced its plans to release its second quarter earnings after 4:00 p.m. Eastern time on Wednesday, July 23, 2025. Covenant Logistics Group, Inc. will hold a live conference call to discuss its second quarter earnings release on Thursday, July 24,

Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2025 Earnings Conference Call

Phillips Edison & Company Inc. Invites You to Join Its Second Quarter 2025 Earnings Conference Call GlobeNewswire July 01, 2025 CINCINNATI, July 01, 2025 (GLOBE NEWSWIRE) — Phillips Edison & Company, Inc. (Nasdaq: PECO) (“PECO” or the “Company”), one of the nation's largest owners and operators of high-quality, grocery-anchored neighborhood shopping centers, will announce its

ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants

ArriVent Announces Proposed $75 Million Public Offering of Common Stock and Pre-Funded Warrants GlobeNewswire July 01, 2025 NEWTOWN SQUARE, Pa., July 01, 2025 (GLOBE NEWSWIRE) — ArriVent BioPharma, Inc. (“ArriVent”) (Nasdaq: AVBP), a clinical-stage company dedicated to accelerating the global development of innovative biopharmaceutical therapeutics, today announced that it intends to offer and sell, subject

Nasdaq Announces the Board of Directors of its U.S. Exchanges

Nasdaq Announces the Board of Directors of its U.S. Exchanges GlobeNewswire July 01, 2025 NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Nasdaq, Inc. (Nasdaq: NDAQ) today announced the election of all nominated directors to the boards of the U.S. exchanges operated by the company, which include The Nasdaq Stock Market LLC, Nasdaq PHLX LLC,

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4)

Definitive Healthcare Corp. reports inducement grants under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire July 01, 2025 FRAMINGHAM, Mass., July 01, 2025 (GLOBE NEWSWIRE) — Definitive Healthcare (Nasdaq: DH), an industry leader in healthcare commercial intelligence, today announced that in connection with the hiring of two senior leaders, the Human Capital Management and Compensation Committee (the “Committee”)

Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction

Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction Further reduction of outstanding debt by Madryn Asset Management improves the Company's balance sheet position GlobeNewswire July 01, 2025 TORONTO, July 01, 2025 (GLOBE NEWSWIRE) — Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on June

Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies

Cue Biopharma Provides Update on Most Advanced Clinical Stage Asset, CUE-101, Presented by Dr. Dimitrios Colevas at the DAVA 4th Hawaii Global Summit on Thoracic Malignancies GlobeNewswire July 01, 2025 ORR of 50% in treatment-naive patients with HPV+ R/M HNSCC12-month landmark survival of 88% and mOS of 32 months BOSTON, July 01, 2025 (GLOBE NEWSWIRE)

Eos Energy Announces Second Funding Under Its Department of Energy Loan Guarantee to Fuel U.S. Battery Manufacturing Capacity Expansion

Eos Energy Announces Second Funding Under Its Department of Energy Loan Guarantee to Fuel U.S. Battery Manufacturing Capacity Expansion $22.7 million second loan advance follows the first $68.3 million received in December 2024 GlobeNewswire July 01, 2025 TURTLE CREEK, Pa., July 01, 2025 (GLOBE NEWSWIRE) — Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos” or the

Scroll to Top